Let's Go1. Study in 3,592 people with type 2 diabetes aged 18 and older comparing baseline therapy to 3 months of Omnipod or Omnipod DASH use. Average A1c at baseline vs. 3-months of Omnipod = 9.2 vs. 7.9%. Ave
This offer is not valid for participants whose Omnipod DASH prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs, or where prohibited by law. Participants on certain commercial insurance plans may not be eligible. This offer is only valid...
With this program, Participants may be eligible to receive a 30-day supply of Omnipod DASH products at no cost for them. Eligible participants have two (2) options, based on the following: • A participant shall sign the 30-day Omnipod DASH Free Trial Acknowledgement through the appropria...
The Program is open to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod 5, Omnipod DASH® or Omnipod Insulin Management System. This offer is not valid for participants whose Omnipod 5 or compatible CGM prescription is ...
Pod Therapy delivers the continuous control of pump therapy, without the tubes or interruptions. Once the Pod is placed on your body and synced with your Omnipod DASH® PDM or the Omnipod 5 App, you’re ready to go. Through the Omnipod DASH PDM, you can enter your glucose value readi...